Fund 1 Investments LLC Sells 1,195,775 Shares of Bath & Body Works, Inc. $BBWI

Fund 1 Investments LLC decreased its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 94.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 74,404 shares of the company’s stock after selling 1,195,775 shares during the period. Fund 1 Investments LLC’s holdings in Bath & Body Works were worth $1,721,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Geneos Wealth Management Inc. increased its position in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares in the last quarter. Danske Bank A S bought a new position in Bath & Body Works in the 3rd quarter valued at about $39,000. Global Retirement Partners LLC bought a new position in Bath & Body Works in the 4th quarter valued at about $31,000. Activest Wealth Management acquired a new position in Bath & Body Works during the 4th quarter valued at about $32,000. Finally, Elevation Wealth Partners LLC boosted its stake in Bath & Body Works by 5,278.8% during the 2nd quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company’s stock valued at $41,000 after purchasing an additional 1,742 shares during the last quarter. 95.14% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts have commented on the company. Barclays decreased their price objective on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a report on Thursday, May 28th. Raymond James Financial reaffirmed a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, May 27th. JPMorgan Chase & Co. upped their price target on Bath & Body Works from $22.00 to $24.00 and gave the stock a “neutral” rating in a report on Tuesday, August 18th. Citigroup raised Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 price target for the company in a research report on Tuesday, August 18th. Finally, UBS Group restated a “neutral” rating on shares of Bath & Body Works in a research note on Wednesday, August 19th. Four research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $22.57.

View Our Latest Stock Report on Bath & Body Works

Bath & Body Works Stock Performance

Shares of BBWI stock opened at $18.92 on Thursday. The company has a market capitalization of $3.81 billion, a price-to-earnings ratio of 5.31, a PEG ratio of 1.73 and a beta of 1.38. Bath & Body Works, Inc. has a 52-week low of $14.27 and a 52-week high of $32.32. The company has a 50-day simple moving average of $20.36 and a two-hundred day simple moving average of $20.01.

Bath & Body Works (NYSE:BBWIGet Free Report) last posted its earnings results on Wednesday, August 26th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.24 by $0.38. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The firm had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.50 billion. During the same quarter last year, the firm earned $0.30 EPS. The company’s quarterly revenue was down 2.3% compared to the same quarter last year. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, sell-side analysts forecast that Bath & Body Works, Inc. will post 2.63 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Investors of record on Friday, August 21st will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 4.2%. The ex-dividend date is Friday, August 21st. Bath & Body Works’s dividend payout ratio (DPR) is 22.47%.

Trending Headlines about Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

  • Positive Sentiment: Bath & Body Works reported second-quarter adjusted EPS of $0.62, well above the $0.24 analyst consensus, while revenue of $1.51 billion slightly exceeded expectations. Bath & Body Works Q2 Earnings and Revenues Surpass Estimates
  • Positive Sentiment: Management raised fiscal 2026 adjusted EPS guidance to $2.60-$2.80, above its previous range of $2.40-$2.65 and ahead of the roughly $2.56 consensus. The company also reiterated revenue expectations of approximately $7.5-$7.6 billion. Bath & Body Works Raises Earnings Outlook on Higher Profit
  • Positive Sentiment: Digital demand and direct-channel sales growth are offsetting weaker physical-store traffic. Management also highlighted ongoing transformation initiatives, including planned cost savings, stronger cash flow and potential balance-sheet improvement that could support future shareholder returns. Bath & Body Works lifts annual profit forecast
  • Neutral Sentiment: The earnings call and bullish commentary frame BBWI as a discounted turnaround opportunity, but investors will likely require sustained sales growth and execution before assigning a higher valuation.
  • Negative Sentiment: Second-quarter net sales declined 2.3% year over year, and third-quarter adjusted EPS guidance of only $0.07-$0.12 is substantially below the approximately $0.27 consensus. The outlook reflects continued near-term pressure from store traffic and seasonality. Bath & Body Works falls despite earnings beat
  • Negative Sentiment: Heavy put-option activity ahead of the report signaled elevated bearish hedging and helps explain the stock’s volatility despite the earnings beat.

About Bath & Body Works

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Featured Stories

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.